Translating the COVID-19 experience in widening the HPV vaccination campaign for cervical cancer in India

India has proven by the success of COVID vaccination that it has a huge production and distribution capacity, availability of professionally trained medical staff, world renowned digital infrastructure to enrol people, conduct camps and maintain records, and a positive mindset among the people towar...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghose, Aruni, Agarwal, Anisha, Sirohi, Bhawna, Nag, Shona, Chuang, Linus, Mitra, Swarupa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Special Section on Global Gynecologic Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363615/
https://www.ncbi.nlm.nih.gov/pubmed/37492441
http://dx.doi.org/10.1016/j.gore.2023.101247
_version_ 1785076668500541440
author Ghose, Aruni
Agarwal, Anisha
Sirohi, Bhawna
Nag, Shona
Chuang, Linus
Mitra, Swarupa
author_facet Ghose, Aruni
Agarwal, Anisha
Sirohi, Bhawna
Nag, Shona
Chuang, Linus
Mitra, Swarupa
author_sort Ghose, Aruni
collection PubMed
description India has proven by the success of COVID vaccination that it has a huge production and distribution capacity, availability of professionally trained medical staff, world renowned digital infrastructure to enrol people, conduct camps and maintain records, and a positive mindset among the people towards vaccination. There is an unmet need to enforce that cervical cancer is a “preventable tragedy,” and vaccination is an invaluable way ahead. With this article, we hope to attract attention to translating India's successful COVID-19 vaccination campaign experience to developing the HPV vaccination campaign.
format Online
Article
Text
id pubmed-10363615
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-103636152023-07-25 Translating the COVID-19 experience in widening the HPV vaccination campaign for cervical cancer in India Ghose, Aruni Agarwal, Anisha Sirohi, Bhawna Nag, Shona Chuang, Linus Mitra, Swarupa Gynecol Oncol Rep Special Section on Global Gynecologic Oncology India has proven by the success of COVID vaccination that it has a huge production and distribution capacity, availability of professionally trained medical staff, world renowned digital infrastructure to enrol people, conduct camps and maintain records, and a positive mindset among the people towards vaccination. There is an unmet need to enforce that cervical cancer is a “preventable tragedy,” and vaccination is an invaluable way ahead. With this article, we hope to attract attention to translating India's successful COVID-19 vaccination campaign experience to developing the HPV vaccination campaign. Elsevier 2023-07-21 /pmc/articles/PMC10363615/ /pubmed/37492441 http://dx.doi.org/10.1016/j.gore.2023.101247 Text en © 2023 Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Special Section on Global Gynecologic Oncology
Ghose, Aruni
Agarwal, Anisha
Sirohi, Bhawna
Nag, Shona
Chuang, Linus
Mitra, Swarupa
Translating the COVID-19 experience in widening the HPV vaccination campaign for cervical cancer in India
title Translating the COVID-19 experience in widening the HPV vaccination campaign for cervical cancer in India
title_full Translating the COVID-19 experience in widening the HPV vaccination campaign for cervical cancer in India
title_fullStr Translating the COVID-19 experience in widening the HPV vaccination campaign for cervical cancer in India
title_full_unstemmed Translating the COVID-19 experience in widening the HPV vaccination campaign for cervical cancer in India
title_short Translating the COVID-19 experience in widening the HPV vaccination campaign for cervical cancer in India
title_sort translating the covid-19 experience in widening the hpv vaccination campaign for cervical cancer in india
topic Special Section on Global Gynecologic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363615/
https://www.ncbi.nlm.nih.gov/pubmed/37492441
http://dx.doi.org/10.1016/j.gore.2023.101247
work_keys_str_mv AT ghosearuni translatingthecovid19experienceinwideningthehpvvaccinationcampaignforcervicalcancerinindia
AT agarwalanisha translatingthecovid19experienceinwideningthehpvvaccinationcampaignforcervicalcancerinindia
AT sirohibhawna translatingthecovid19experienceinwideningthehpvvaccinationcampaignforcervicalcancerinindia
AT nagshona translatingthecovid19experienceinwideningthehpvvaccinationcampaignforcervicalcancerinindia
AT chuanglinus translatingthecovid19experienceinwideningthehpvvaccinationcampaignforcervicalcancerinindia
AT mitraswarupa translatingthecovid19experienceinwideningthehpvvaccinationcampaignforcervicalcancerinindia

Ejemplares similares